A carregar...

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study

OBJECTIVE: The objective of this study was to assess the efficacy, safety and tolerability of vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter pylori eradication therapy. DESIGN: A randomised, double-blind, multicentre, parallel-group study was conducted to veri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gut
Main Authors: Murakami, Kazunari, Sakurai, Yuuichi, Shiino, Madoka, Funao, Nobuo, Nishimura, Akira, Asaka, Masahiro
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5036253/
https://ncbi.nlm.nih.gov/pubmed/26935876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2015-311304
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!